Lv0
0 积分 2026-01-15 加入
Therapeutic induction of antigen-specific immune tolerance
2个月前
已完结
IL-10 in cancer: an essential thermostatic regulator between homeostatic immunity and inflammation – a comprehensive review
2个月前
已完结
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
2个月前
已完结
Managing heart failure in diabetics with dual acting sotagliflozin—A review
2个月前
已关闭
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
2个月前
已完结
Hydrogen-bonded structures and interaction energies in two forms of the SGLT-2 inhibitor sotagliflozin
2个月前
已完结
Dual SGLT1/2 inhibition with sotagliflozin: a pharmaceutical breakthrough in heart failure management and cardiometabolic risk reduction
2个月前
已关闭
A Review of Sotagliflozin: The First Dual SGLT-1/2 Inhibitor
2个月前
已完结
Process Development of Sotagliflozin, a Dual Inhibitor of Sodium–Glucose Cotransporter-1/2 for the Treatment of Diabetes
2个月前
已完结
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control
4个月前
已完结
皖公网安备34019202002308
